Taher Al‐Tweigeri

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

Medicine, Oncology, Pharmacology +13

The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors

Hazem Ghebeh, Shamayel Mohammed, Abeer Al-Omair et al. · Neoplasia · 2006 · 629 citations · Full text

Life Sciences, Oncology, Pathology +17

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells

Abdullah Alsuliman, Dilek Çolak, Olfat Al‐Harazi et al. · Molecular Cancer · 2015 · 314 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

Hazem Ghebeh, Cynthia Lehé, Eman Barhoush et al. · Breast Cancer Research · 2010 · 235 citations · Full text

Medicine, Oncology, Pharmacology +13

FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

Hazem Ghebeh, Eman Barhoush, Asma Tulbah et al. · BMC Cancer · 2008 · 222 citations · Full text

Life Sciences, Immunology, Oncology +16